EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Eleven Bio CFO Perry Heads to Aegerion

Xconomy Boston — 

Former Eleven Biotherapeutics (NASDAQ: EBIO) chief financial officer Gregory Perry has been named the new CFO of Aegerion Pharmaceuticals (NASDAQ: AEGR). Aside from Eleven Bio, Perry has also served in executive roles at InVivo Therapeutics, ImmunoGen, and Transkaryotic Therapeutics.